Tansey Casey M

Tansey Casey M has demonstrated a consistent buying pattern across two companies, with no recorded sales in 29 reported transactions totaling $651,908.71 in purchases. The activity is concentrated in Inspire Medical Systems (INSP), with recent acquisitions of $17,461.07 on January 15, 2026, and $17,423.64 on October 14, 2025. These purchases follow a series of smaller transactions in HTFL and SI, though most of these earlier filings—particularly 17 transactions in HTFL on August 11, 2025—show no reported dollar value, suggesting they may involve grants, conversions, or other non-market transactions. The only significant monetary activity outside INSP was a $600,000 purchase in SI on August 1, 2025, coded as a derivative transaction (likely options or warrants). The absence of sell-side activity and the recurring acquisitions in INSP indicate a clear accumulation strategy, particularly in the medical technology sector. While the HTFL and SI transactions lack monetary details, their volume suggests administrative or equity-based adjustments rather than discretionary trading. Tansey’s most recent moves—two near-identical INSP buys within three months—reinforce a focused, bullish stance on the company, contrasting with the earlier, less transparent activity in HTFL and SI. The pattern reflects a preference for long-term holdings over short-term disposals, with no indication of profit-taking or diversification.